These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 19192435

  • 1. A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.
    Rothbaum BO, Davidson JR, Stein DJ, Pedersen R, Musgnung J, Tian XW, Ahmed S, Baldwin DS.
    J Clin Psychiatry; 2008 Oct; 69(10):1529-39. PubMed ID: 19192435
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ.
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [Abstract] [Full Text] [Related]

  • 3. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
    Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J.
    Arch Gen Psychiatry; 2006 Oct; 63(10):1158-65. PubMed ID: 17015818
    [Abstract] [Full Text] [Related]

  • 4. Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.
    Stein DJ, Pedersen R, Rothbaum BO, Baldwin DS, Ahmed S, Musgnung J, Davidson J.
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):23-31. PubMed ID: 18544181
    [Abstract] [Full Text] [Related]

  • 5. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 6. Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo.
    Davidson J, Stein DJ, Rothbaum BO, Pedersen R, Szumski A, Baldwin DS.
    J Psychopharmacol; 2012 Jun; 26(6):778-83. PubMed ID: 21926426
    [Abstract] [Full Text] [Related]

  • 7. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD.
    J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
    [Abstract] [Full Text] [Related]

  • 8. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
    Davidson J, Baldwin DS, Stein DJ, Pedersen R, Ahmed S, Musgnung J, Benattia I, Rothbaum BO.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
    Liebowitz MR, Asnis G, Mangano R, Tzanis E.
    J Clin Psychiatry; 2009 Apr; 70(4):550-61. PubMed ID: 19358784
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E.
    JAMA; 2000 Jun 21; 283(23):3082-8. PubMed ID: 10865302
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM.
    JAMA; 2000 Apr 12; 283(14):1837-44. PubMed ID: 10770145
    [Abstract] [Full Text] [Related]

  • 12. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.
    J Clin Psychiatry; 2002 Mar 12; 63(3):199-206. PubMed ID: 11926718
    [Abstract] [Full Text] [Related]

  • 13. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR, Gelenberg AJ, Munjack D.
    Arch Gen Psychiatry; 2005 Feb 12; 62(2):190-8. PubMed ID: 15699296
    [Abstract] [Full Text] [Related]

  • 14. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
    Kroenke K, Messina N, Benattia I, Graepel J, Musgnung J.
    J Clin Psychiatry; 2006 Jan 12; 67(1):72-80. PubMed ID: 16426091
    [Abstract] [Full Text] [Related]

  • 15. Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.
    Ferguson JM, Khan A, Mangano R, Entsuah R, Tzanis E.
    J Clin Psychiatry; 2007 Jan 12; 68(1):58-68. PubMed ID: 17284131
    [Abstract] [Full Text] [Related]

  • 16. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K, Perry CM.
    CNS Drugs; 2001 Jan 12; 15(8):643-69. PubMed ID: 11524036
    [Abstract] [Full Text] [Related]

  • 17. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.
    J Clin Psychiatry; 2006 Oct 12; 67(10):1522-6. PubMed ID: 17107242
    [Abstract] [Full Text] [Related]

  • 18. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R, Chen J, Entsuah AR, Schatzberg AF.
    J Clin Psychiatry; 2003 Mar 12; 64(3):321-30. PubMed ID: 12716275
    [Abstract] [Full Text] [Related]

  • 19. Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial.
    Fann JR, Bombardier CH, Richards JS, Wilson CS, Heinemann AW, Warren AM, Brooks L, McCullumsmith CB, Temkin NR, Warms C, Tate DG, PRISMS Investigators.
    JAMA Psychiatry; 2015 Mar 12; 72(3):247-58. PubMed ID: 25607727
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH, Salinas E.
    J Clin Psychiatry; 2001 Jul 12; 62(7):523-9. PubMed ID: 11488362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.